Paula Soteropoulos
Director · 4 filings · Latest: May 21, 2026
Dianthus Therapeutics, Inc. /DE/
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DNTH | Paula Soteropoulos | Director | May 8, 2026 | Sale | $85.47 | 599 | $51.2K | 0 | |
DNTH | Paula Soteropoulos | Director | May 8, 2026 | Option Exercise | $8.44 | 599 | $5.1K | 599 | |
DNTH | Paula Soteropoulos | Director | Mar 31, 2026 | Sale | $80.11 | 599 | $48.0K | 0 | |
DNTH | Paula Soteropoulos | Director | Mar 31, 2026 | Option Exercise | $8.44 | 599 | $5.1K | 599 | |
DNTH | PAULA C SOTEROPOULOS | — | Mar 31, 2026 | Proposed Sale | $79.45 | 1,198 | $95.2K | — | |
DNTH | Paula Soteropoulos | Director | Mar 24, 2026 | Sale | $78.05 | 27,594 | $2.2M | 0 | |
DNTH | Paula Soteropoulos | Director | Mar 24, 2026 | Option Exercise | $8.44 | 27,594 | $232.9K | 27,594 | |
DNTH | PAULA C SOTEROPOULOS | — | Mar 24, 2026 | Proposed Sale | $79.32 | 27,594 | $2.2M | — |